Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours
DNA polymerase theta (Polθ)-mediated end joining (TMEJ) is, along with homologous recombination (HR) and non-homologous end-joining (NHEJ), one of the most important mechanisms repairing potentially lethal DNA double-strand breaks (DSBs). Polθ is becoming a new target in cancer research because it d...
Main Authors: | Gabriela Barszczewska-Pietraszek, Małgorzata Drzewiecka, Piotr Czarny, Tomasz Skorski, Tomasz Śliwiński |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/1/319 |
Similar Items
-
Synthetic Lethality Targeting Polθ
by: Małgorzata Drzewiecka, et al.
Published: (2022-06-01) -
Multifaceted Nature of DNA Polymerase θ
by: Alexander A. Kruchinin, et al.
Published: (2023-02-01) -
Excess Polθ functions in response to replicative stress in homologous recombination-proficient cancer cells
by: T. Goullet de Rugy, et al.
Published: (2016-10-01) -
Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells
by: Małgorzata Drzewiecka, et al.
Published: (2023-08-01) -
Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction
by: Elena Clementi, et al.
Published: (2020-03-01)